Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "Wang-Soo Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Basic Research
Article image
Application of Animal Models in Diabetic Cardiomyopathy
Wang-Soo Lee, Jaetaek Kim
Diabetes Metab J. 2021;45(2):129-145.   Published online March 25, 2021
DOI: https://doi.org/10.4093/dmj.2020.0285
  • 21,772 View
  • 458 Download
  • 27 Web of Science
  • 30 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
Diabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunction in patients with DM in the absence of coronary artery disease and hypertension. The underlying pathomechanism of DiaCM is partially understood, but accumulating evidence suggests that metabolic derangements, oxidative stress, increased myocardial fibrosis and hypertrophy, inflammation, enhanced apoptosis, impaired intracellular calcium handling, activation of the renin-angiotensin-aldosterone system, mitochondrial dysfunction, and dysregulation of microRNAs, among other factors, are involved. Numerous animal models have been used to investigate the pathomechanisms of DiaCM. Despite some limitations, animal models for DiaCM have greatly advanced our understanding of pathomechanisms and have helped in the development of successful disease management strategies. In this review, we summarize the current pathomechanisms of DiaCM and provide animal models for DiaCM according to its pathomechanisms, which may contribute to broadening our understanding of the underlying mechanisms and facilitating the identification of possible new therapeutic targets.

Citations

Citations to this article as recorded by  
  • Insights into INS Gene Variation from Seven Years of Monogenic Diabetes Testing—Novel Genetic Variants and Their Clinical Implications
    Tomasz Płoszaj, Patrycja Mojsak, Sebastian Skoczylas, Katarzyna Piekarska, Maciej Borowiec, Barbara Salmonowicz, Leszek Czupryniak, Małgorzata Mysliwiec, János András Mótyán, Krisztina Tar, Agnieszka Zmysłowska
    Applied Sciences.2026; 16(2): 795.     CrossRef
  • Investigating the biomarkers of diabetic-cardiomyopathy with the high mobility group box-1 as a potential anti-inflammatory therapeutic target: Systematic Review and meta-analysis
    Ranmali Ranasinghe, Michael Mathai, Anthony Zulli
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Transcriptional regulatory network analysis uncovers modular gene control and potential key regulators in diabetic cardiomyopathy
    Fernanda Fredericksen, Víctor Aliaga-Tobar, Sebastián Aedo-Cares, Jorge Torres, Sebastián Leiva-Navarrete, Darío Parra-Cofré, Daniel Uribe, Ángel Raya, Alex Di Genova, Rodrigo Troncoso, Valentina Parra, Mauricio Latorre
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
  • Modulation of the gut-heart axis by exercise in diabetic cardiomyopathy: Microbial mechanisms and clinical implications
    Jun Chen, Zhiwei Fan, Yuan Li, Rui Duan, Binghong Gao
    iScience.2026; 29(4): 115490.     CrossRef
  • Melanocortin Receptor Signaling Modulates Anti-Obesity and Glucose Tolerance Effects of Hafnia alvei 4597 Probiotic Strain in Mice
    Vasiliy A. Zolotarev, Vladimir O. Murovets, Egor A. Sozontov, Anastasia L. Sepp, Ekaterina A. Lukina, Raisa P. Khropycheva, Benjamin Thomas, Sergueï O. Fetissov
    International Journal of Molecular Sciences.2026; 27(15): 6963.     CrossRef
  • O-GlcNAc modification of CaMKII-mediated mitophagic flux regulation via HSPB8 in diabetic cardiomyopathy
    Yanjuan Jiang, Kaibo Hu, Zhaowei Luo, Huiwen Duan, Xinrui Qi, Xuehong Zheng, Jing Zhang, Fang Zou, Xia Cai, Liyan Niu, Peng Yu, Xiaoyang Lai
    Clinical Science.2026; 140(8): 1779.     CrossRef
  • Tongmai Hypoglycemic Capsule Attenuates Myocardial Oxidative Stress and Fibrosis in the Development of Diabetic Cardiomyopathy in Rats
    Jie-qiong Zeng, Hui-fen Zhou, Hai-xia Du, Yu-jia Wu, Qian-ping Mao, Jun-jun Yin, Hai-tong Wan, Jie-hong Yang
    Chinese Journal of Integrative Medicine.2025; 31(3): 251.     CrossRef
  • Mechanistic insight into the role of cardiac-enriched microRNAs in diabetic heart injury
    Branislav Kura, Lucia Kindernay, Dinender Singla, Ulrika Dulova, Monika Bartekova
    American Journal of Physiology-Heart and Circulatory Physiology.2025; 328(4): H865.     CrossRef
  • Pulmonary effects of waterpipe generated smoke in adult diabetic rats
    Rima Kamel, Sibelle Kassouf, Selim M. Nasser, Amale Mcheik, Nathalie Hayeck, Elias Abi-Ramia, Hanan ElKazzaz, Christian Khalil, Aniella Abi-Gerges
    Toxicology and Applied Pharmacology.2025; 499: 117319.     CrossRef
  • Ranolazine as a therapeutic agent for diabetic cardiomyopathy: reducing endoplasmic reticulum stress and inflammation in type 2 diabetic rat model
    Matin Mohyadini, Aghele Fahimi, S. Zahra Bathaie, Hamid Yaghooti
    BMC Pharmacology and Toxicology.2025;[Epub]     CrossRef
  • Interaction between mitochondrial oxidative stress and myocardial fibrosis in the context of diabetes
    Pu-Hua Zhang, Nuo-Nan Li, Xiang Gu, Chun-Xia Zhou, Zhen-Zhen Jiang, Xian-Jun Luo, Hong-Wen Zhu, Xiao-Yong Zhu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • High-Fat Diet-Induced Diabetic Cardiomyopathy in Female Zebrafish: Cardiac Pathology and Functional Decline Mediated by Type 2 Diabetes
    Shuaiwang Huang, Zhanglin Chen, Haoming Li, Yunyi Zou, Bihan Wang, Wenjun Zhao, Lan Zheng, Zuoqiong Zhou, Xiyang Peng, Changfa Tang
    Nutrients.2025; 17(13): 2209.     CrossRef
  • Cross-regulation of methylation and oxidative stress: molecular mechanisms and intervention strategies of diabetic cardiomyopathy
    Ya-qi Guo, Jia-yin Zhang, Pan-pan Hou, Chen-xi Jia, Tian-lu Zhu, Qi-rui Zhang, Zheng-wei Du, Dan-jie Li, Yu-ting Xi, Qian-qian Niu, Peng Li
    European Journal of Pharmacology.2025; 1005: 178080.     CrossRef
  • Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model
    Georgică Târtea, Aurel Popa-Wagner, Veronica Sfredel, Smaranda Ioana Mitran, Alexandra Oltea Dan, Anca-Maria Țucă, Alexandra Nicoleta Preda, Victor Raicea, Eugen Țieranu, Dragoș Cozma, Radu Vătășescu
    International Journal of Molecular Sciences.2024; 25(4): 2118.     CrossRef
  • Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targets
    Wanlin Ye, Kun Han, Maodi Xie, Sheyu Li, Guo Chen, Yanyan Wang, Tao Li
    Chinese Medical Journal.2024; 137(8): 936.     CrossRef
  • Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus
    Shatha M. Alobaid, Rahaf M. Alshahrani, Asma S. Alonazi, Nawal M. Alrasheed, Maha A. Alamin, Tahani K. Alshammari, Anfal F. Bin Dayel, Doaa M. Elnagar, Rana R. Alotaibi, Lama A. Almuthnabi, Dalia H. Almasud, Shahad E. Al-Ammar, Shahad O. Almadhi, Reema A.
    Pharmaceuticals.2024; 17(3): 374.     CrossRef
  • An Overview of Diabetic Cardiomyopathy
    Abdul Quaiyoom, Ranjeet Kumar
    Current Diabetes Reviews.2024;[Epub]     CrossRef
  • Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs
    Yasodha Krishna Janapati, Sunil Junapudi
    Animal Models and Experimental Medicine.2024; 7(3): 297.     CrossRef
  • The role of NF-κB in diabetic cardiomyopathy
    Huang-Jun Liu, Le-Kun Gui, Han Wei, Xing-Yu Zhou, Zhen-Lan Liu, Li-Jun Jin
    All Life.2024;[Epub]     CrossRef
  • A reliable strategy for establishment of an animal model of diabetic cardiomyopathy: Induction by a high-fat diet combined with single or multiple injections of low-dose streptozotocin
    Weixing Wen, Yue Cao, Peng Chen, Jiahuan Li, Weiwen Li, Guolin Huang, Haoxiao Zheng, Xiaolin Zhu, Hao Zhang, Yangxin Chen, Xiaohui Huang, Yunzhao Hu, Yuli Huang
    Life Sciences.2024; 358: 123161.     CrossRef
  • Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
    Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
    International Journal of Heart Failure.2023; 5(1): 1.     CrossRef
  • Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
    Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
    Diabetes & Metabolism Journal.2023; 47(1): 10.     CrossRef
  • Machine learning for spatial stratification of progressive cardiovascular dysfunction in a murine model of type 2 diabetes mellitus
    Andrya J. Durr, Anna S. Korol, Quincy A. Hathaway, Amina Kunovac, Andrew D. Taylor, Saira Rizwan, Mark V. Pinti, John M. Hollander, Yoshihiro Fukumoto
    PLOS ONE.2023; 18(5): e0285512.     CrossRef
  • Hyperglycemic memory in diabetic cardiomyopathy
    Jiabing Zhan, Chen Chen, Dao Wen Wang, Huaping Li
    Frontiers of Medicine.2022; 16(1): 25.     CrossRef
  • Murine Models of Obesity
    Tânia Martins, Catarina Castro-Ribeiro, Sílvia Lemos, Tiago Ferreira, Elisabete Nascimento-Gonçalves, Eduardo Rosa, Paula Alexandra Oliveira, Luís Miguel Antunes
    Obesities.2022; 2(2): 127.     CrossRef
  • The Role of Mitochondria in Metabolic Syndrome–Associated Cardiomyopathy
    Jiayu Li, Jingye Li, Yijun Chen, Wenyu Hu, Xuhe Gong, Hui Qiu, Hui Chen, Yanguo Xin, Hongwei Li, Tao Li
    Oxidative Medicine and Cellular Longevity.2022;[Epub]     CrossRef
  • Guidelines on models of diabetic heart disease
    Lisa C. Heather, Anne D. Hafstad, Ganesh V. Halade, Romain Harmancey, Kimberley M. Mellor, Paras K. Mishra, Erin E. Mulvihill, Miranda Nabben, Michinari Nakamura, Oliver J. Rider, Matthieu Ruiz, Adam R. Wende, John R. Ussher
    American Journal of Physiology-Heart and Circulatory Physiology.2022; 323(1): H176.     CrossRef
  • Extracellular vesicle therapy for non-ischemic heart failure: A systematic review of preclinical studies
    Ramana Vaka, Sophie Van Remortel, Valentina Ly, Darryl R. Davis
    Extracellular Vesicle.2022; 1: 100009.     CrossRef
  • Effect of a Six-week Endurance Exercise Program and Empagliflozin Consumption on Some Structural and Functional Indices of the Heart in Male Diabetic Rats
    Eftekhar Mohammadi, Mohammad Fathi, Farzaneh Chehel Cheraghi, Afshin Nazari
    journal of ilam university of medical sciences.2022; 30(3): 1.     CrossRef
  • Cardiac Phosphodiesterases Are Differentially Increased in Diabetic Cardiomyopathy
    Rita Hanna, Wared Nour-Eldine, Youakim Saliba, Carole Dagher-Hamalian, Pia Hachem, Pamela Abou-Khalil, Delphine Mika, Audrey Varin, Magali Samia El Hayek, Laëtitia Pereira, Nassim Farès, Grégoire Vandecasteele, Aniella Abi-Gerges
    Life Sciences.2021; 283: 119857.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP